The vector of anti-GPC3 T cell receptor (TCR) is constructed for the engineering of T cell to target Human GPC3. The T cells are genetically modified through transduction with a lentiviral vector expressing GPC3-specific T cell receptor. And the vector product was designed for the treatment of Hepatocellular carcinoma.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
|VP-CAR-LC262||Lenti-GPC3 CAR (scFv-CD4-FcεRIγ, 9C2) Viral Particle|
|VP-CAR-LC265||Lenti-GPC3 CAR (scFv-41BB-CD3ζ, 9C2) Viral Particle|
|CAR-T-2-L342-8Z||Anti-GPC3 scFv h(CD8-CD3ζ) CART, pCDCAR1|
|VP-CAR-LC540||Lenti-GPC3 CAR (scFv-41BB-CD3ζ, GC33) Viral Particle|
|VP-CAR-LC267||Lenti-GPC3 CAR (scFv-CD28-41BB-CD3ζ, 9C2) Viral Particle|
|VP-CAR-LC663||Lenti-GPC3 CAR (scFv-CD28-41BB-CD3ζ, 3E11) Viral Particle|
|CAR-LC047||Anti-GPC3 (GC33) h(CD28-CD3ζ) CAR, pCDCAR1|
|CAR-LC092||Anti-GPC3 h(41BB-CD3ζ) CAR, pCDCAR1|
|OAdCmodV-YX1259||Oncolytic Adenovirus (Capsid modified Ad5, phTERT-Δ24/55k, Anti-GPC3-2), Viral particle|
|CAR-T-1-L342-G||Anti-GPC3 scFv h(FcεRIγ) CART, pCDCAR1|
Copyright © 2007 - 2018 Creative Biolabs. All Rights Reserved